Baseline circulating immature neutrophils anticipate hyperprogressive disease (HPD) upon 1st-line PD-1/PD-L1 inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients (pts) and are reduced by platinum-based chemotherapy (PCT) and ICI combinations

Autor: Ferrara, R, Lo Russo, G, Ciniselli, Cm, Gregorio, S, Calareso, G, Bassani, B, Proto, C, Prelaj, A, De Toma, A, Occhipinti, M, Brambilla, M, Manglaviti, S, Mazzeo, L, Beninato, T, Ganzinelli, M, De Braud, Fgm, Garassino, Mc, Colombo, Mp, Verderio, P, Sangaletti, S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3686::a671b2c081bd84fae20f51f0a3580313
https://hdl.handle.net/11573/1662819

Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma

Autor: FRANCO, Giovanni, GUARNOTTA, Carla, Piccaluga, PP, Boveri, E, GULINO, Alessandro, Fuligni, F, Rigoni, A, Porcasi, R, Buffa, S, Betto, E, FLORENA, Ada Maria, FRANCO, Vito, Iannitto, E, Arcaini, L, Pileri, SA, Pucillo, C, Colombo, MP, Sangaletti, S, TRIPODO, Claudio, Frossi, B, PORCASI, Rossana

Publikováno v: Blood. 123:1836-1849

Splenic marginal zone lymphoma (SMZL) is a mature B-cell neoplasm characterized by rather indolent clinical course. However, nearly one third of patients experience a rapidly progressive disease with a dismal outcome. Despite the characterization of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c81ddcba47a294954a517075af1690
https://doi.org/10.1182/blood-2013-04-497271

The bone marrow stroma in hematological neoplasms-a guilty bystander

Autor: TRIPODO, Claudio, FRANCO, Giovanni, Sangaletti, S, Piccaluga, PP, Prakash, S, Borrello, I, Orazi, A, Colombo, MP, Pileri, S.A.

In the setting of hematological neoplasms, changes in the bone marrow (BM) stroma might arise from pressure exerted by the neoplastic clone in shaping a supportive microenvironment, or from chronic perturbation of the BM homeostasis. Under such condi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::d9772f3e2a66a1bf07d02514c2ed8f29
http://hdl.handle.net/10447/60709

Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009

Autor: Maio, M, Nicolay, Hj, Ascierto, Pa, Belardelli, F, Camerini, R, Colombo, Mp, Queirolo, P, Ridolfi, R, Russo, V, Fonsatti, E, Parmiani, G, Allavena P, N. I. B. I. T., Anichini, A, Bellone, M, Bronte, V, Calabrò, L, Camisaschi, C, Castelli, C, Danova, M, Di Giacomo AM, Di Nicola, M, Ferlazzo, G, Giovannoni, L, Hwu, P, Lehmann, F, Maccalli, C, Melero, I, Monsurro', Vladia, Montagna, D, Moschella, F, Ponzoni, M, Protti, Mp, Puccetti, P, Sangiolo, D, Schuler, G.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::230245899205cbaa4f49d53e6db2b295
http://hdl.handle.net/11365/1081278

The role of PLZF in melanoma progression

Autor: (1) Felicetti F, (1) Bottero L, (1) Felli N, (1) Mattia G, (1)Labbaye C, (2) Alvino E, (1) Peschle C, (3)Colombo MP, (1) Care' A.

Publikováno v: Oncogene (Basingstoke) 23/26 (2004): 4567–4576.
info:cnr-pdr/source/autori:(1) Felicetti F, (1) Bottero L, (1) Felli N, (1) Mattia G, (1)Labbaye C, (2) Alvino E, (1) Peschle C, (3)Colombo MP, (1) Care' A./titolo:The role of PLZF in melanoma progression./doi:/rivista:Oncogene (Basingstoke)/anno:2004/pagina_da:4567/pagina_a:4576/intervallo_pagine:4567–4576/volume:23%2F26

The promyelocytic leukemia zinc finger (PLZF) protein has been described as a transcriptional repressor of homeobox (HOX)-containing genes during embryogenesis. As we previously demonstrated a functional link between overexpression of HOXB7 and melan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::b920edd6b5977e4542287371054de995
http://www.cnr.it/prodotto/i/4479